Misys Prepares to Support Banks for FRTB Compliance

Vendor readying enhanced FusionCapital Risk solution

mark-feeley
Mark Feeley, global head of capital markets, Misys

Misys is readying enhancements to its FusionCapital Risk solution, adding capabilities aimed at supporting banks with their market risk calculations under the Fundamental Review of the Trading Book regulation.

The solution addresses the standardized approach requirements off the shelf and offers add-on services to help firms comply with the internal model approach, according to Misys.

The vendor is leveraging existing capabilities of FusionCapital Risk to address the performance and calculation

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

CME: CFTC OKs clearing move to Google Cloud

The CFTC has given the Chicago-based exchange approval to run its clearing and settlement infrastructure on the Google Cloud Platform, while the exchange and vendor have extended their partnership to last until at least 2037.

Cutting through the hype surrounding the FDTA rulemaking process

A bill requiring US regulators and institutions to adopt a machine-readable data framework for reporting purposes applies to entity identifiers, but not security identifiers, in a crucial difference, writes Scott Preiss, SVP and global head of Cusip Global Services.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here